30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

William Doyle

Track

Insider profile

Currently holds positions in Novocure Ltd, OptiNose Inc and Minerva Neurosciences Inc

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -11% 8.2% 15.1%
Success rate 17% 68% 82%
Transactions
34 38% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Chairman of the Board Novocure Ltd May 11, 2016 -
Independent Director OptiNose Inc Jan. 1, 2010 -
Lead Independent Director Minerva Neurosciences Inc Feb. 5, 2018 -
Director Minerva Neurosciences Inc Dec. 11, 2017 - Feb. 5, 2018
Independent Director Zoetis Inc Feb. 3, 2015 - May 12, 2016
Chairman of the Board Novocure Ltd Jan. 1, 2004 - May 11, 2016
William Doyle's trades of Novocure Ltd's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-05 2026-03-03
US Novocure Ltd (NVCR)
S Sale
57,703 -31.2%
87.96
US$3,445,289 		57,703 -31.2% 87.96 US$3,445,289
2026-03-05 2026-03-03
US Novocure Ltd (NVCR)
S Sale
47,305 -26.9%
428.84
US$3,752,328 		47,305 -26.9% 428.84 US$3,752,328
2026-03-03 2026-03-03
US Novocure Ltd (NVCR)
PrS Proposed sale
10,852
372.94
US$3,065,796 		10,852 372.94 US$3,065,796
2024-05-23 2024-05-21
B Purchase
15,000 +24.5%
16.98
US$254,700 		15,000 +24.5% 16.98 US$254,700
2024-03-12 2024-03-08
B Purchase
15,000 +32.4%
16.30
US$244,500 		15,000 +32.4% 16.30 US$244,500
2022-08-03 2022-08-02
US Novocure Ltd (NVCR)
S Sale
837 -0.2%
69.66
US$58,305 		837 -0.2% 69.66 US$58,305
2022-03-09 2022-03-08
US Novocure Ltd (NVCR)
S Sale
2,385 -0.4%
70.10
US$167,188 		2,385 -0.4% 70.10 US$167,188
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
600 -0.1%
216.69
US$130,016 		600 -0.1% 216.69 US$130,016
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
500 -0.1%
214.67
US$107,332 		500 -0.1% 214.67 US$107,332
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
1,500 -0.3%
213.35
US$320,020 		1,500 -0.3% 213.35 US$320,020
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
600 -0.1%
211.28
US$126,766 		600 -0.1% 211.28 US$126,766
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
521 -0.1%
210.18
US$109,504 		521 -0.1% 210.18 US$109,504
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
2,200 -0.4%
209.34
US$460,555 		2,200 -0.4% 209.34 US$460,555
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
4,500 -0.8%
207.80
US$935,118 		4,500 -0.8% 207.80 US$935,118
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
1,284 -0.2%
206.35
US$264,956 		1,284 -0.2% 206.35 US$264,956
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
1,600 -0.3%
205.43
US$328,690 		1,600 -0.3% 205.43 US$328,690
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
1,972 -0.3%
204.28
US$402,834 		1,972 -0.3% 204.28 US$402,834
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
2,555 -0.4%
203.25
US$519,311 		2,555 -0.4% 203.25 US$519,311
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
4,388 -0.8%
202.16
US$887,069 		4,388 -0.8% 202.16 US$887,069
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
4,125 -0.7%
201.55
US$831,377 		4,125 -0.7% 201.55 US$831,377
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
4,338 -0.7%
199.71
US$866,355 		4,338 -0.7% 199.71 US$866,355
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
10,563 -1.8%
198.98
US$2,101,794 		10,563 -1.8% 198.98 US$2,101,794
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
13,612 -2.2%
197.83
US$2,692,876 		13,612 -2.2% 197.83 US$2,692,876
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
24,338 -3.8%
197.00
US$4,794,659 		24,338 -3.8% 197.00 US$4,794,659
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
8,814 -1.4%
196.07
US$1,728,187 		8,814 -1.4% 196.07 US$1,728,187
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
1,600 -0.2%
194.94
US$311,904 		1,600 -0.2% 194.94 US$311,904
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
2,090 -0.3%
193.57
US$404,563 		2,090 -0.3% 193.57 US$404,563
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
1,900 -0.3%
192.52
US$365,796 		1,900 -0.3% 192.52 US$365,796
2021-04-15 2021-04-13
US Novocure Ltd (NVCR)
PlS Planned sale
1,400 -0.2%
191.26
US$267,768 		1,400 -0.2% 191.26 US$267,768
2021-04-02 2021-04-01
US Novocure Ltd (NVCR)
S Sale
7,928 -1.2%
134.12
US$1,063,303 		7,928 -1.2% 134.12 US$1,063,303
2020-08-03 2020-07-31
US Novocure Ltd (NVCR)
S Sale
896 -0.1%
76.39
US$68,444 		896 -0.1% 76.39 US$68,444
2020-05-12 2020-05-11
US Novocure Ltd (NVCR)
S Sale
31,332 -4.6%
63.73
US$1,996,726 		31,332 -4.6% 63.73 US$1,996,726
2020-05-11 2020-05-08
US Novocure Ltd (NVCR)
S Sale
31,903 -4.5%
63.50
US$2,025,872 		31,903 -4.5% 63.50 US$2,025,872
2020-05-11 2020-05-07
US Novocure Ltd (NVCR)
S Sale
30,993 -4.5%
64.74
US$2,006,518 		30,993 -4.5% 64.74 US$2,006,518
2020-05-07 2020-05-06
US Novocure Ltd (NVCR)
S Sale
29,881 -5.0%
64.27
US$1,920,452 		29,881 -5.0% 64.27 US$1,920,452
2020-05-07 2020-05-05
US Novocure Ltd (NVCR)
S Sale
30,283 -4.8%
62.47
US$1,891,718 		30,283 -4.8% 62.47 US$1,891,718
2020-03-10 2020-03-06
US Novocure Ltd (NVCR)
S Sale
4,320 -0.8%
69.53
US$300,387 		4,320 -0.8% 69.53 US$300,387
2020-03-02 2020-02-28
US Novocure Ltd (NVCR)
S Sale
3,893 -0.8%
72.22
US$281,133 		3,893 -0.8% 72.22 US$281,133
2020-01-22 2020-01-17
US Novocure Ltd (NVCR)
PlS Planned sale
133,777 -20.8%
95.00
US$12,708,815 		133,777 -20.8% 95.00 US$12,708,815
2019-07-01 2019-06-27
B Purchase
3,500 +15.5%
5.50
US$19,250 		3,500 +15.5% 5.50 US$19,250
2019-06-03 2019-05-30
US Novocure Ltd (NVCR)
S Sale
48,100 -5.4%
53.07
US$2,552,523 		48,100 -5.4% 53.07 US$2,552,523
2019-05-31 2019-05-29
US Novocure Ltd (NVCR)
S Sale
1,900 -0.2%
53.10
US$100,880 		1,900 -0.2% 53.10 US$100,880
2019-05-10 2019-05-09
US Novocure Ltd (NVCR)
S Sale
31,460 -3.4%
47.37
US$1,490,386 		31,460 -3.4% 47.37 US$1,490,386
2019-05-09 2019-05-08
US Novocure Ltd (NVCR)
S Sale
32,218 -3.6%
47.52
US$1,531,032 		32,218 -3.6% 47.52 US$1,531,032
2019-05-09 2019-05-07
US Novocure Ltd (NVCR)
S Sale
32,098 -3.7%
47.67
US$1,530,112 		32,098 -3.7% 47.67 US$1,530,112